BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8102975)

  • 21. Spinal antinociception by Tyr-D-Ser(otbu)-Gly-Phe-Leu-Thr, a selective delta-opioid receptor agonist.
    Kalso EA; Sullivan AF; McQuay HJ; Dickenson AH
    Eur J Pharmacol; 1992 May; 216(1):97-101. PubMed ID: 1326441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are Phe-Met-Arg-Phe-NH2 immunoreactive peptides endacoids modulating opiate antinociception?
    Yang HY; Tang J; Iadarola M; Panula P; Costa E
    Prog Clin Biol Res; 1985; 192():313-22. PubMed ID: 3909160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FMRF-amide and L-Arg-L-Phe increase blood pressure and heart rate in the anaesthetised rat by central stimulation of the sympathetic nervous system.
    Thiemermann C; al-Damluji S; Hecker M; Vane JR
    Biochem Biophys Res Commun; 1991 Feb; 175(1):318-24. PubMed ID: 1998514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgG from antiserum against endogenous mammalian FMRF-NH2-related peptides augments morphine- and stress-induced analgesia in mice.
    Kavaliers M; Yang HY
    Peptides; 1989; 10(4):741-5. PubMed ID: 2587416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of mammalian FMRF-NH2-related peptides and IgG from antiserum against them on aggression and defeat-induced analgesia in mice.
    Kavaliers M; Yang HY
    Peptides; 1991; 12(2):235-9. PubMed ID: 2067975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.
    Chen SR; Pan HL
    Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat.
    Oberling P; Stinus L; Le Moal M; Simonnet G
    Peptides; 1993; 14(5):919-24. PubMed ID: 8284268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential analgesic effects of a mu-opioid peptide, [Dmt(1)]DALDA, and morphine.
    Shimoyama M; Szeto HH; Schiller PW; Tagaito Y; Tokairin H; Eun Cm; Shimoyama N
    Pharmacology; 2009; 83(1):33-7. PubMed ID: 18987489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats.
    Million M; Fioramonti J; Gicquel S; Zajac JM; Bueno L
    J Pharmacol Exp Ther; 1993 Apr; 265(1):96-102. PubMed ID: 8474035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-lasting antinociceptive effects of a novel dynorphin analogue, Tyr-D-Ala-Phe-Leu-Arg psi (CH(2)NH) Arg-NH(2), in mice.
    Hiramatsu M; Inoue K; Ambo A; Sasaki Y; Kameyama T
    Br J Pharmacol; 2001 Apr; 132(8):1948-56. PubMed ID: 11309268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal oxymetazoline produces analgesia via spinal alpha-adrenoceptors and potentiates spinal morphine.
    Sherman SE; Loomis CW; Milne B; Cervenko FW
    Eur J Pharmacol; 1988 Apr; 148(3):371-80. PubMed ID: 2838306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the antinociceptive effects of new [D-Arg2]-dermorphin tetrapeptide analogs and morphine in mice.
    Chaki K; Sakurada S; Sakurada T; Sato T; Kawamura S; Kisara K; Watanabe H; Suzuki K
    Pharmacol Biochem Behav; 1988 Oct; 31(2):439-44. PubMed ID: 2907624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The actions of FMRF-NH2 and FMRF-NH2 related peptides on mammals.
    Raffa RB
    NIDA Res Monogr; 1990; 105():243-9. PubMed ID: 1678861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin.
    Gendron L; Esdaile MJ; Mennicken F; Pan H; O'Donnell D; Vincent JP; Devi LA; Cahill CM; Stroh T; Beaudet A
    Neuroscience; 2007 Jan; 144(1):263-74. PubMed ID: 17055663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of Phe-Met-Arg-Phe-NH2 (FMRFamide) on morphine-induced inhibition of colonic propulsive motility in mice.
    Jacoby MB; Jacoby HI; Mathiasen JR; Raffa RB
    Neurosci Lett; 1987 Dec; 83(1-2):128-32. PubMed ID: 3441291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathecal FMRFamide (Phe-Met-Arg-Phe-NH2) induces excessive grooming behavior in mice.
    Raffa RB; Heyman J; Porreca F
    Neurosci Lett; 1986 Mar; 65(1):94-8. PubMed ID: 2422608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An assessment of the antinociceptive efficacy of intrathecal and epidural contulakin-G in rats and dogs.
    Allen JW; Hofer K; McCumber D; Wagstaff JD; Layer RT; McCabe RT; Yaksh TL
    Anesth Analg; 2007 Jun; 104(6):1505-13, table of contents. PubMed ID: 17513650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of gastric acid secretion by central administration of FMRFamide in rats.
    Muthal AV; Chopde CT
    Indian J Med Res; 1993 Aug; 98():185-7. PubMed ID: 7903282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ontogeny of the F8Famide-like (morphine-modulating) peptides in the central nervous system of rats.
    Kivipelto L; Rubenstein J; Yang HY; Panula P
    J Comp Neurol; 1991 Feb; 304(1):14-33. PubMed ID: 1673130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.